Our analyses revealed that the occurrence and development mechanisms of RIPK2 in human tumours were mainly associated with NOD-like signalling pathways, the NF-kappa B signalling pathway, I-kappa B kinase/NF-kappa B signalling, ribonucleoprotein granule and ubiquitin-like protein ligase binding. This evidence concerns the gene CHUK and neoplasm.